SCHEMBL6208314

SCHEMBL6208314

CCS(=O)(=O)c1cccc(OC)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 1/20 0.53
PSIP1 O75475 1/20 0.52
NFE2L2 Q16236 2/20 0.51
FFAR4 Q5NUL3 1/20 0.51
KEAP1 Q14145 1/20 0.51
PGR P06401 4/20 0.51
MEP1B Q16820 1/20 0.51
TAS2R14 Q9NYV8 1/20 0.50
MEN1 O00255 1/20 0.50
POLB P06746 1/20 0.50
GAA P10253 1/20 0.50
MAPT P10636 1/20 0.50
RAB9A P51151 1/20 0.50
KMT2A Q03164 1/20 0.50
MTNR1B P49286 1/20 0.49
ESR1 P03372 1/20 0.49
CA1 P00915 2/20 0.49
CA2 P00918 2/20 0.49
CA9 Q16790 2/20 0.49
CA12 O43570 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4250924 0.89 HSD11B1 (0.53) HSD11B1NFE2L2FFAR4KEAP1PGR
SCHEMBL11986344 0.87 NFE2L2 (0.51) HSD11B1NFE2L2FFAR4KEAP1PGR
SCHEMBL13370691 0.85 CA12 (0.50) HSD11B1NFE2L2FFAR4KEAP1PGR
SCHEMBL7324279 0.85 HSD11B1 (0.50) HSD11B1NFE2L2FFAR4KEAP1PGR
SCHEMBL11986349 0.84 HSD11B1 (0.47) HSD11B1NFE2L2FFAR4KEAP1PGR
SCHEMBL20314695 0.84 MMP13 (0.47) HSD11B1NFE2L2FFAR4KEAP1PGR
SCHEMBL14773591 0.83 TP53 (0.52) PSIP1MEN1GAAMAPTKMT2A
SCHEMBL14326955 0.82 HSD11B1 (0.51) HSD11B1NFE2L2FFAR4KEAP1PGR
SCHEMBL4188124 0.82 HSD11B1 (0.48) HSD11B1NFE2L2FFAR4KEAP1PGR
SCHEMBL3151230 0.82 MTNR1B (0.56) NFE2L2FFAR4KEAP1PGRMEP1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180179151-A1 SULFONAMIDE DERIVATIVE AND PHARMACEUTICALLY ACCEPTABLE ACID ADDITION SALT THEREOF UNIVERSITY OF TSUKUBA (JP) 2018-06-28 US disclosed
US-20150105396-A1 Chemical Compounds PFIZER LTD (GB) 2015-04-16 US disclosed
US-7932284-B2 Indole sulfonamide modulators of progesterone receptors ELI LILLY AND COMPANY (US) 2011-04-26 US disclosed
US-20090069400-A1 Indole Sulfonamide Modulators of Progesterone Receptors ELI LILLY AND COMPANY 2009-03-12 US disclosed
EP-1188747-B1 PHENOXYPROPYLAMINE COMPOUNDS MITSUBISHI PHARMA CORP (JP) 2005-09-07 EP disclosed
EP-1188747-A1 PHENOXYPROPYLAMINE COMPOUNDS Mitsubishi Pharma Corporation (JP) 2002-03-20 EP disclosed
US-5672615-A MATRIX-DEGRADING METALLOPROTEINASE INHIBITORS NOVARTIS CORPORATION (US) 1997-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180179151-A1 SULFONAMIDE DERIVATIVE AND PHARMACEUTICALLY ACCEPTABLE ACID ADDITION SALT THEREOF HCRTR2, HCRTR1, NPSR1 HSD11B1 538/4885PSIP1 3260/4885NFE2L2 3322/4885
US-20090069400-A1 Indole Sulfonamide Modulators of Progesterone Receptors PGR, NPSR1, PRLHR HSD11B1 319/4885PSIP1 1852/4885NFE2L2 2576/4885
US-20150105396-A1 Chemical Compounds GABRA5, GABRA4, GABRA3 HSD11B1 947/4885PSIP1 3000/4885NFE2L2 1758/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.